Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients

Breast Cancer Research

Volumn 6, Issue 4, 2004, Pages

  Retsky, Michael ^a   Bonadonna, Gianni ^b   Demicheli, Romano ^b   Folkman, Judah ^a   Hrushesky, William ^c   Valagussa, Pinuccia ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

adjuvant chemotherapy; angiogenesis; breast cancer dormancy; mammography controversy; surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; LYMPH NODE; MASTECTOMY; METHODOLOGY; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PREMENOPAUSE; PROGNOSIS; SURVIVAL; THEORETICAL MODEL; TUMOR RECURRENCE;

ADULT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODES; MASTECTOMY; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PREMENOPAUSE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 4344587881     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr804     Document Type: Article

References (13)

1. M. Retsky R. Demicheli W. Hrushesky Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy Breast Cancer Res Treat 2001 65 217 224 1:STN:280:DC%2BD3M3mt12mug%3D%3D 10.1023/A:1010626302152 11336243
2. M. Baum M.A.J. Chaplain A.R.A. Anderson M. Douek J.S. Vaidya Does breast cancer exist in a state of chaos? Eur J Cancer 1999 35 886 891 1:STN:280:DC%2BD3c%2FgtlKlsg%3D%3D 10.1016/S0959-8049(99)00067-2 10533467
3. M.S. O'Reilly L. Holmgren Y. Shing C. Chen R.A. Rosenthal M. Moses W.S. Lane Y. Cao E.H. Sage J. Folkman Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 1994 79 315 328 10.1016/0092-8674(94)90200-3 7525077
4. S.O. Hofer G. Molema R.A. Hermens H.J. Wanebo J.S. Reichner H.J. Hoekstra The effect of surgical wounding on tumour development Eur J Surg Oncol 1999 25 231 243 1:STN:280:DyaK1M3ntVylsg%3D%3D 10.1053/ejso.1998.0634 10336800
5. M. Retsky R. Demicheli W. Hrushesky Breast cancer screening: controversies and future directions Curr Opin Obstet Gynecol 2003 15 1 8 10.1097/00001703-200302000-00001 12544495
6. R. Demicheli G. Bonadonna W.J.M. Hrushesky M.W. Retsky P. Valagussa Menopausal status dependence of the early mortality reduction due to diagnosing smaller breast cancers (T1 versus T2-T3): relevance to screening J Clin Oncol 2004 22 102 107 10.1200/JCO.2004.12.139 14701771
7. C. Baines Mammography screening: are women really giving informed consent? J Natl Cancer Inst 2003 95 1508 1511 10.1093/jnci/djg026 14559870
8. G.N. Naumov I.C. MacDonald P.M. Weinmeister N. Kerkvliet K.V. Nadkarni S.M. Wilson V.L. Morris A.C. Groom A.F. Chambers Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy Cancer Res 2002 62 2162 2168 1:CAS:528:DC%2BD38XivVyksr4%3D 11929839
9. G. Bonadonna P. Valagussa A. Moliterni M. Zambetti C. Brambilla Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up N Engl J Med 1995 332 901 906 1:STN:280:DyaK2M7otlSqsg%3D%3D 10.1056/NEJM199504063321401 7877646
10. NIH consensus conference Adjuvant chemotherapy for breast cancer JAMA 1985 254 3461 3463 10.1001/jama.1985.03360240073038
11. Early Breast Cancer Trialists' Collaborative Group Polychemotherapy for early breast cancer: an overview of the randomised trials Lancet 1998 352 930 942 10.1016/S0140-6736(98)03301-7
12. A.B. Miller T. To C.J. Baines C. Wall The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years Ann Intern Med 2002 137 305 312 10.7326/0003-4819-137-5_Part_1-200209030-00005 12204013
13. R. Demicheli R. Miceli C. Brambilla L. Ferrari A. Moliterni M. Zambetti P. Valagussa G. Bonadonna Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures' Breast Cancer Res Treat 1999 53 209 215 1:STN:280:DyaK1M3psFOnsw%3D%3D 10.1023/A:1006134702484 10369067